{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:34:32Z","timestamp":1777361672873,"version":"3.51.4"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2618,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Chronic graft dysfunction, manifesting with elevated liver enzymes and histological features of interface hepatitis (IH), is being increasingly recognized as a long-term problem after liver transplantation. The aim of this study was to characterize our group of post\u2013orthotopic liver transplantation (OLT) patients with respect to clinical, laboratory, and histological signs of IH. A retrospective study of charts and liver biopsy specimens from patients transplanted between 1986 and 1999 was used. Histological features of IH were found in 29\/119 patients at a median interval of 23.9 months (95% confidence interval \u221228.2 to 52.6) after OLT. All patients with IH had risk factors for chronic rejection, such as steroid-resistant rejection, acute rejection later than 3 months post-OLT, female receiver of male graft, or pretransplant cytomegalovirus (CMV)-positive serology with a CMV-negative donor liver. None of the 29 had features favoring a diagnosis of <jats:italic toggle=\"yes\">de novo<\/jats:italic> autoimmune hepatitis, but 4 had isolated hypergammaglobulinemia, and 4 had non\u2013organ-specific autoantibodies without hyperimmunoglobulin G. Sixteen of 29 patients also had features of chronic rejection, such as foam cell arteriopathy, loss of bile ducts, or pericentral fibrosis. After abnormal biopsy, all but 1 patient were switched to tacrolimus. During a median follow-up of 12 years, death occurred in 5, retransplantation occurred in 7, and definite cirrhosis occurred in 4. In conclusion, IH was detected in 24.4% of our patients and was associated with a high degree of fibrosis development. Most likely, IH represents a form of chronic rejection directed against periportal hepatocytes. Liver Transpl 14:946\u2013955, 2008. \u00a9 2008 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.21444","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T19:47:51Z","timestamp":1214423271000},"page":"946-955","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":64,"title":["Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients"],"prefix":"10.1097","volume":"14","author":[{"given":"Denise","family":"Herzog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doroth\u00e9e Bouron-Dal","family":"Soglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Fournet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Marleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20250326","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/lt.20826","article-title":"Longterm outcomes of 600 living donor liver transplants for pediatric patients at a single centre.","volume":"12","author":"Ueda","year":"2006","journal-title":"Liver Transpl"},{"key":"R2-8-20250326","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/jlts.2002.34149","article-title":"Longterm survival and late graft loss in pediatric liver transplant recipientsa 15year singlecentre experience.","volume":"8","author":"Wallot","year":"2002","journal-title":"Liver Transpl"},{"key":"R3-8-20250326","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/hep.21152","article-title":"Progressive histological damage in liver allografts following pediatric liver transplantation.","volume":"43","author":"Evans","year":"2006","journal-title":"Hepatology"},{"key":"R4-8-20250326","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/lt.20673","article-title":"Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience.","volume":"12","author":"Riva","year":"2006","journal-title":"Liver Transpl"},{"key":"R5-8-20250326","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/jhep.2003.50231","article-title":"All liver recipients benefit from the protocol 10year liver biopsies.","volume":"37","author":"Sebagh","year":"2003","journal-title":"Hepatology"},{"key":"R6-8-20250326","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/jhep.2002.31726","article-title":"Histologic and biochemical changes during the evolution of chronic rejection in liver allografts.","volume":"35","author":"Neil","year":"2002","journal-title":"Hepatology"},{"key":"R7-8-20250326","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00007890-200209270-00017","article-title":"Centrilobular fibrosis in longterm followup of pediatric liver transplant recipients.","volume":"74","author":"Martin","year":"2002","journal-title":"Transplantation"},{"key":"R8-8-20250326","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"Denovo autoimmune hepatitis after liver transplantation.","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"R9-8-20250326","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation.","volume":"71","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"key":"R10-8-20250326","first-page":"131","article-title":"Autoimmune hepatitis as a late complication of liver transplantation.","volume":"32","author":"Hernandez","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R11-8-20250326","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.","volume":"34","author":"Heneghan","year":"2001","journal-title":"Hepatology"},{"key":"R12-8-20250326","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/jhep.2002.35339","article-title":"Autoimmunity after liver transplantation.","volume":"36","author":"Vergani","year":"2002","journal-title":"Hepatology"},{"key":"R13-8-20250326","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0168-8278(00)80309-8","article-title":"Development of ductopaenic liver allograft rejection includes a hepatitic phase prior to duct loss.","volume":"33","author":"Quaglia","year":"2000","journal-title":"J Hepatol"},{"key":"R14-8-20250326","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel.","volume":"31","author":"Demetris","year":"2000","journal-title":"Hepatology"},{"key":"R15-8-20250326","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the Committee for Autoimmune Serology of the International Autoimmune Hepatitis Group.","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"R16-8-20250326","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis.","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R17-8-20250326","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1542-3565(04)00396-9","article-title":"Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful?","volume":"2","author":"Ebbeson","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R18-8-20250326","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C.","volume":"20","year":"1994","journal-title":"Hepatology"},{"key":"R19-8-20250326","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C.","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"R20-8-20250326","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/jlts.2001.23085","article-title":"Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome.","volume":"7","author":"Hubscher","year":"2001","journal-title":"Liver Transpl"},{"key":"R21-8-20250326","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis.","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"R23-8-20250326","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0168-8278(00)80175-0","article-title":"Autoantibodies associated with acute rejection after liver transplantation for type2 autoimmune hepatitis.","volume":"33","author":"DuclosVallee","year":"2000","journal-title":"J Hepatol"},{"key":"R24-8-20250326","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/hep.1840130514","article-title":"Chronic rejection after liver transplantation: a study of clinical histopathological and immunological features.","volume":"13","author":"Freese","year":"1991","journal-title":"Hepatology"},{"key":"R25-8-20250326","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/00007890-199312000-00020","article-title":"Ethnic variations in patient and graft survival after liver transplantation. Identification of a new risk factor for chronic allograft rejection.","volume":"56","author":"Devlin","year":"1993","journal-title":"Transplantation"},{"key":"R26-8-20250326","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0046-8177(99)90298-8","article-title":"Fibrosiscirrhosis after orthotopic liver transplantation.","volume":"1","author":"Tabatabai","year":"1999","journal-title":"Hum Pathol"},{"key":"R27-8-20250326","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/00000478-199911000-00003","article-title":"Analysis of the reversibility of chronic liver allograft rejection implications for a staging schema.","volume":"23","author":"Blakolmer","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R28-8-20250326","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s005340170003","article-title":"Pathogenesis and treatment of bile duct loss after liver transplantation.","volume":"8","author":"Inomata","year":"2001","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R29-8-20250326","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/00007890-200004150-00047","article-title":"A large, single center investigation of the immunogenetic factors affecting liver transplantation.","volume":"69","author":"Doran","year":"2000","journal-title":"Transplantation"},{"key":"R30-8-20250326","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence.","volume":"52","author":"DuclosVallee","year":"2003","journal-title":"Gut"},{"key":"R31-8-20250326","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.transproceed.2004.12.113","article-title":"Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence.","volume":"37","author":"Nakhleh","year":"2005","journal-title":"Transplant Proc"},{"key":"R32-8-20250326","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00007890-200001150-00007","article-title":"An association between cytomegalovirus infection and chronic rejection after liver transplantation.","volume":"69","author":"Evans","year":"2000","journal-title":"Transplantation"},{"key":"R33-8-20250326","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/nm1312","article-title":"Lymphopenia and interleukin2 therapy alter homeostasis of CD4CD25 regulatory T cells.","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat Med"},{"key":"R34-8-20250326","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/01.TP.0000056168.79903.20","article-title":"The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimusbased immunosuppression: a longterm analysis.","volume":"75","author":"Jain","year":"2003","journal-title":"Transplantation"},{"key":"R35-8-20250326","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2003.10.022","article-title":"De novo autoimmune hepatitis after liver transplantation.","volume":"40","author":"MieliVergani","year":"2004","journal-title":"J Hepatol"},{"issue":"pt 2","key":"R36-8-20250326","first-page":"2208","article-title":"Criteria for the histopathological classification of liver allograft rejection and their clinical significance.","volume":"21","author":"Kemnitz","year":"1989","journal-title":"Transplant Proc"},{"key":"R37-8-20250326","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2005.01299.x","article-title":"Risk groups for clinical complications of norovirus infections: an outbreak investigation.","volume":"12","author":"Mattner","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R38-8-20250326","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/JVI.77.1.405-415.2003","article-title":"Norwalk viruslike particle hemagglutination by binding to histoblood group antigens.","volume":"77","author":"Hutson","year":"2003","journal-title":"J Virol"},{"key":"R39-8-20250326","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1086\/427779","article-title":"Association of histoblood group antigens and susceptibility to norovirus infections.","volume":"191","author":"Rocks","year":"2005","journal-title":"J Infect Dis"},{"key":"R40-8-20250326","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1080\/01926230600918876","article-title":"Pathology of immunodeficient mice with naturally occurring murine norovirus infection.","volume":"34","author":"Ward","year":"2006","journal-title":"Toxicol Pathol"},{"key":"R41-8-20250326","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.tp.0000258646.54562.c7","article-title":"Experimental and clinical significance of antinuclear antibodies in liver transplantation.","volume":"83","author":"Nakano","year":"2007","journal-title":"Transplantation"},{"key":"R42-8-20250326","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MPG.0b013e31805ce219","article-title":"Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation.","volume":"45","author":"Avitzur","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R43-8-20250326","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000478-200404000-00006","article-title":"Autoimmune hepatitis with centrilobular necrosis.","volume":"28","author":"Misdraji","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R44-8-20250326","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/gast.1997.v113.pm9247489","article-title":"A novel histological lesion in glucocorticoidresponsive chronic hepatitis.","volume":"113","author":"Pratt","year":"1997","journal-title":"Gastroenterology"},{"key":"R45-8-20250326","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/gut.41.2.269","article-title":"Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis.","volume":"41","author":"Te","year":"1997","journal-title":"Gut"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21444","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200807000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:24:12Z","timestamp":1743272652000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200807000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.21444","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}